ZA945275B - Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor - Google Patents

Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor

Info

Publication number
ZA945275B
ZA945275B ZA945275A ZA945275A ZA945275B ZA 945275 B ZA945275 B ZA 945275B ZA 945275 A ZA945275 A ZA 945275A ZA 945275 A ZA945275 A ZA 945275A ZA 945275 B ZA945275 B ZA 945275B
Authority
ZA
South Africa
Prior art keywords
cav
virus
vaccines
induction
proteins
Prior art date
Application number
ZA945275A
Other languages
English (en)
Inventor
Mathieu Hubertus Maria Noteborn
Guus Koch
Original Assignee
Aesculaap Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aesculaap Bv filed Critical Aesculaap Bv
Publication of ZA945275B publication Critical patent/ZA945275B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA945275A 1993-07-20 1994-07-19 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor ZA945275B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9301272A NL9301272A (nl) 1993-07-20 1993-07-20 Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.

Publications (1)

Publication Number Publication Date
ZA945275B true ZA945275B (en) 1995-02-24

Family

ID=19862681

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945275A ZA945275B (en) 1993-07-20 1994-07-19 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor

Country Status (13)

Country Link
US (1) US5952002A (nl)
EP (2) EP1253201B1 (nl)
JP (1) JP3829290B2 (nl)
AT (2) ATE236980T1 (nl)
AU (1) AU703187B2 (nl)
CA (1) CA2167578C (nl)
DE (2) DE69432486T2 (nl)
DK (2) DK0784685T3 (nl)
ES (2) ES2311005T3 (nl)
NL (1) NL9301272A (nl)
PT (2) PT1253201E (nl)
WO (1) WO1995003414A2 (nl)
ZA (1) ZA945275B (nl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
US6162461A (en) * 1990-09-12 2000-12-19 Leadd B.V. Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
EP0872552A1 (en) * 1997-04-15 1998-10-21 Leadd B.V. A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or Apoptin
EP0878546A1 (en) * 1997-04-15 1998-11-18 Leadd B.V. A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
DK0830604T3 (da) * 1995-06-07 2003-09-29 Leadd Bv Anvendelser af apoptin
EP0832242A1 (en) * 1995-06-07 1998-04-01 Aesculaap B.V. Neutralizing conformational epitopes of chicken anemia virus
EP0927757A1 (en) * 1997-12-03 1999-07-07 Leadd B.V. Methods and means for inducing apoptosis by interfering with Bip-like proteins
US7361730B1 (en) * 1999-03-15 2008-04-22 University Of Maryland Surface localized colligin/Hsp47 in carcinoma cells
EP1199363A1 (en) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylation modifications of apoptin
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
ES2572736T3 (es) 2005-12-29 2016-06-02 Boehringer Ingelheim Vetmedica, Inc. Uso de una composición inmunógena para atenuar síntomas clínicos en cerdos
CN102698263B (zh) 2005-12-29 2016-07-06 贝林格尔.英格海姆维特梅迪卡有限公司 多价pcv2免疫原性组合物和制备此类组合物的方法
CN102311928B (zh) * 2011-08-25 2013-04-24 中国农业科学院哈尔滨兽医研究所 鸡贫血病毒vp1、vp2蛋白共表达的重组酵母工程菌、其构建方法及应用
RU2771533C2 (ru) 2015-10-16 2022-05-05 Канзас Стейт Юниверсити Рисерч Фаундейшн Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения
CN109312351B9 (zh) * 2016-04-26 2020-10-23 伦敦卫生及热带医学学院 呼肠孤病毒科疫苗
CN113980146B (zh) * 2021-11-11 2022-09-27 扬州优邦生物药品有限公司 三聚体化鸭黄病毒E蛋白domainIII、其制备方法和运用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.

Also Published As

Publication number Publication date
DK0784685T3 (da) 2003-08-04
DE69432486D1 (de) 2003-05-15
EP0784685B1 (en) 2003-04-09
CA2167578A1 (en) 1995-02-02
NL9301272A (nl) 1995-02-16
WO1995003414A3 (en) 1995-03-02
JP3829290B2 (ja) 2006-10-04
US5952002A (en) 1999-09-14
EP1253201B1 (en) 2008-07-16
WO1995003414A2 (en) 1995-02-02
DE69432486T2 (de) 2004-03-04
AU7547394A (en) 1995-02-20
PT784685E (pt) 2003-08-29
JPH09504941A (ja) 1997-05-20
ATE401406T1 (de) 2008-08-15
DE69435117D1 (de) 2008-08-28
ES2196032T3 (es) 2003-12-16
ES2311005T3 (es) 2009-02-01
EP1253201A3 (en) 2003-01-08
EP1253201A2 (en) 2002-10-30
DK1253201T3 (da) 2008-11-17
CA2167578C (en) 2007-03-13
AU703187B2 (en) 1999-03-18
ATE236980T1 (de) 2003-04-15
PT1253201E (pt) 2008-10-27
EP0784685A2 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
ZA945275B (en) Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2, and VP3 or sequences of that virus coding therefor
BR9712592A (pt) Processo para gerar um clone infeccioso, ácido nucléico recombinante, molécula do mesmo, vìrus de rna modificado, célula infectada com o mesmo, vacina, proteìna e/ou antìgeno, e, ensaio diagnóstico
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
DE69519521D1 (de) Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
DE69536138D1 (de) Rekombinantes Herpesvirus aus Truthähnen und seine Verwendungen
AU3069889A (en) Pox virus vectors
GR860914B (en) Expression of immunologically reactive viral proteins
MXPA03002751A (es) Fragmentos polipeptidicos del virus de la hepatitis e, composicion de vacuna y equipos de diagnostico que comprenden los mismos.
EP0294469A4 (en) VACCINES AND DIAGNOSTIC ANALYSIS FOR HAEMOPHILUS INFLUENZAE.
DK0491824T4 (da) Humane parvovirus B19-proteiner og viruslignende partikler, deres fremstilling og anvendelse til diagnostiske bestemmelser og vacciner
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
AU3379693A (en) Vaccines and diagnostic assays for haemophilus influenzae
ATE223492T1 (de) Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe
ZA200400289B (en) Chimeric chains that code for proteins that induce effects directed against viruses.
NZ309172A (en) Neutralizing conformational epitopes of chicken anemia virus
GR3003754T3 (nl)
DE69019092D1 (de) Von Babesia abgeleitete Antigene und Polypeptide (12D3-Antigen).
Li et al. Cloning of HBV S Gene with Artificial Mutation Sites in ‘a’Determinant and Analyzing the Protein Antigenicity Expressed
Zelnik et al. Animal herpesviruses and their potential use as polyvalent recombinant vaccines
RU92004487A (ru) Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов